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Abstract
Motivated by genetic association studies of SNPs with genotype uncertainty,
we propose a generalization of the Kruskal–Wallis test that incorporates group
uncertainty when comparing k samples. The extended test statistic is based on
probability-weighted rank-sums and follows an asymptotic chi-square distribu-
tion with k−1 degrees of freedom under the null hypothesis. Simulation studies
confirm the validity and robustness of the proposed test in finite samples. Ap-
plication to a genome-wide association study of type 1 diabetic complications
further demonstrates the utilities of this generalized Kruskal–Wallis test for
studies with group uncertainty.
Keywords: Genome-wide association studies; Imputation; k-sample problem;
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1 Introduction
The seminal work by Kruskal and Wallis (1952) provided us a robust rank-based test
for the k-sample problem, complementing the parametric approaches such as the one-
way analysis of variance (ANOVA). In the classical k-sample problem, data are well
classified into different categories or groups. However, in many current scientific stud-
ies the categorical variables are not necessarily deterministic, and the uncertainties
are quantitatively expressed by probability distributions over attributes. Such classi-
fication problems often arise in biomedical and bioinformatics applications where data
mining techniques and classification algorithms are used to obtain class membership
probabilities.
A particular motivating example of this work is the genetic association study of sin-
gle nucleotide polymorphisms (SNPs) for which the genotype group assignments are
often known with ambiguity. The data uncertainties at these SNPs are typically rep-
resented by genotype probabilities obtained from various genotype calling algorithms
(e.g. Carvalho et al., 2010) or imputation algorithms (e.g. Li et al., 2009). Table 1
provides a hypothetical illustration. In such cases, a number of parametric remedies
have been proposed, including the popular dosage approach, the weighted regres-
sion method (Aulchenko et al., 2010) and likelihood-based score tests (Schaid et al.,
2002). Although these parametric approaches are satisfactory in many applications,
investigators often seek complimentary evidence provided by robust non-parametric
alternatives, safeguarding their statistical analyses against potential model misspec-
ifications. Therefore, it is of both theoretical and practical importance to generalize
the Kruskal–Wallis test so that it is applicable to the k-sample problem but with
group uncertainty.
To formulate the testing problem, let Y be a continuous response variable and G
a categorical variable with k distinct attributes. For instance, in genetic association
studies, Y denotes the phenotype of interest (e.g. blood pressure or glucose level)
and G is the genotype variable at a particular SNP with k = 3. The three categories
for a SNP represent if an individual’s genotype at this SNP contain 0, 1 or 2 copies of
the minor allele (one of the two alleles with population frequency < 0.5). The goal of
the association analysis between Y and G is to determine if the phenotype Y values
differ between individuals with different genotype G values. This can be achieved,
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Table 1. An illustration of SNP genotype probabilities
Individual Genotype hard call soft call
0 1 2
1 0.925 0.045 0.030 0 0.105
2 0.156 0.102 0.742 2 1.586
...
...
...
...
N 0.375 0.410 0.215 1 0.840
for example, by regressing Y on G and other relevant covariates. Hence, the classic
linear model
Yj = µ+ β Gj + εj, j = 1, 2, . . . , N, (1)
with εj
iid
∼ N(0, σ2), provides a basis for most association analysis or group compar-
isons. However, results from the robust Kruskal–Wallis test are often obtained as
preliminary or complimentary evidence.
In practice, what is available to us may not be the true G group value, but rather
probabilistic data of G, i.e. the vector of group probabilities pj = (p1j , p2j, · · · , pkj),
where pij = P (Gj = i) for i = 1, 2, . . . , k and j = 1, 2, . . . , N , with
∑k
i=1 pij = 1.
In genetic association studies of SNPs, depending on the experiment used by each
application, the genotype of a SNP may be inferred via classification algorithms (e.g.
Birdseed, (Korn et al., 2008)), imputed via imputation algorithms, (e.g. TUNA
(Nicolae, 2006), MaCH (Li et al., 2006) and Impute (Marchini et al., 2007)), or
derived from next generation sequencing calling algorithms (e.g. SYZYGY (Calvo
et al., 2010) and SNVer (Wei et al., 2011)). In each case, an individual’s genotype is
most likely associated with some level of uncertainty and the probability that the true
genotype belongs to each of the three genotype groups, pij = P (Gj = i) for i = 0, 1, 2
is provided for individual j, as illustrated in Table 1.
In the presence of genotype group uncertainty, the best-guess approach (also
known as the hard-call approach) bypasses the problem of incomplete group infor-
mation by using the most probable group, G˜j = {i : pij = max(p0j , p1j, p2j)}, in
place of Gj in (1). Depending on whether G˜j are considered ordinal or categori-
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cal, a t-test (df = 1) or an ANOVA F -test (df = 2) can be performed, so is the
Kruskal–Wallis test (df = 2). We refer to these tests as Best-Guess Linear Model
(BG-LM), Best-Guess ANOVA (BG-ANOVA) and Best-Guess Kruskal–Wallis (BG-
KW), respectively (Table 2). Although convenient, this best-guess approach fails to
fully utilize the information in the group probabilities.
An alternative method is the dosage approach (also known as the expectation-
substitution or soft-call approach). In this approach, each Gj in (1) is substituted
by its expectation G¯j = p1j + 2 × p2j . The association evidence is then assessed, for
example, by a t-test (df = 1) from the regression of Y on G¯. We refer to this test
as the dosage test. The main disadvantage of this approach is that it does not allow
G to be of categorical nature, and it constrains the relationship between Y and G
to an additive model. There are several other model-based methods that incorporate
group probabilities (e.g. Marchini et al., 2007; Lin et al., 2008; Kutalik et al., 2010;
Aulchenko et al., 2010; Schaid et al., 2002), however, model-free counterparts such as
the Kruskal–Wallis test has not been proposed.
The remaining paper is organized as follows. In Section 2, we describe the con-
struction of the generalized Kruskal–Wallis test statistic based on intuitive probability-
weighted rank-sums, and provide theoretical justifications of its asymptotic chi-square
distribution. We show that the original Kruskal–Wallis test is a special case of the
proposed test and discuss how to handle tied observations and possible variations in
probabilistic data. Section 3 contains simulation studies to evaluate the finite sample
performance of the proposed test at different levels of group uncertainty. Section 4
applies the method to data from a genome-wide association study of complications in
type 1 diabetic patients. Section 5 concludes with additional discussions. Additional
simulation results are provided in the Supplemental Material.
2 The Generalized Kruskal–Wallis Test
2.1 Notation and the Original Kruskal–Wallis Test
Consider a random sample of size N from a large population consisting of k ≥ 2
disjoint groups or categories, with population proportions πi, i = 1, . . . , k, and∑k
i=1 πi = 1. Denote by G the categorical variable taking values on G = {1, 2, . . . , k}
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and suppose that each category is adequately represented in the sample. Of interest is
to compare the k groups, of sizes n1, . . . , nk with
∑k
i=1 ni = N , based on a continuous
response variable Y . Formally, letting the distribution function of Y over the group
i be of the form Fi(y) = F (y − θi), we wish to test
H0 : θ1 = θ2 = · · · = θk against HA : not all θi’s are equal. (2)
When the precise category assignment of G is available, the Kruskal–Wallis test
for (2) is performed by ranking all the observations together and comparing the sum
of the ranks for each group. Let rj be the rank of Yj in the overall sample and define
the indicator variable Zij = 1(Gj = i) for the group membership, the Kruskal–Wallis
test statistic is
H =
12
N(N + 1)
k∑
i=1
R2i
ni
− 3(N + 1), (3)
where ni =
∑N
j=1 Zij and
Ri =
N∑
j=1
Zijrj.
Under the null hypothesis of (2), H follows an asymptotic chi-square distribution
with k − 1 degrees of freedom (Kruskal, 1952; Kruskal and Wallis, 1952).
2.2 The generalized Kruskal–Wallis Test
Suppose available to are not G but probabilistic data of G, pj = (p1j , p2j, · · · , pkj),
where pij = P (Gj = i) for i = 1, 2, . . . , k and j = 1, 2, . . . , N , with
∑k
i=1 pij = 1. In
this case, it is intuitive to consider the weighted rank-sum
R∗i =
N∑
j=1
pijrj (4)
for each group as a basis of comparison.
However, direct replacement of Ri with R
∗
i in the original Kruskal–Wallis test
statistic (3) does not lead to a properly calibrated test statistic. Below we describe the
construction of the generalized Kruskal–Wallis test, based on this appealing weighted
rank-sum R∗i , that has an asymptotic chis-square distribution with k − 1 degrees of
freedom.
We make the following assumptions.
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(A1) pj’s are independent of Yj’s.
(A2) p¯i =
∑N
j=1 pij/N → πi , as N →∞, with 0 < πi < 1.
(A3)
∑N
j=1(pij − p¯i)
2/N → νi > 0, as N →∞.
(A4)
∑N
j=1(pij − p¯i)(pi′j − p¯i′)√∑N
j=1(pij − p¯i)
2
∑N
j=1(pi′j − p¯i′)
2
→ ρii′ as N →∞.
The independence assumption (A1) is standard in statistical analyses of explana-
tory/response data and is reasonable in practice because, for instance, most impu-
tation algorithms do not consider the phenotype data in the classification of the
genotype variable (Marchini and Howie, 2010). The assumption (A2) ensures that∑N
j=1 pij provides a reasonable approximation for ni and that the relative group sizes
are convergent. Assumptions (A3) and (A4) are required for the (joint) asymptotic
normality of the linear rank statistic R∗i .
If the groups are indeed from an identical population, the rj’s can be viewed
as a random sample drawn without replacement from the first N integers. Thus,
E(rj) = (N +1)/2, Var(rj) = (N
2− 1)/12 and Cov(rj, rj′) = −(N +1)/12, for j 6= j
′
under the null hypothesis of (2). The conditional mean and the conditional variance
of R∗i given the group probabilities pij can then be derived as
E(R∗i ) = µ˜i =
N + 1
2
N∑
j=1
pij and Var(R
∗
i ) = σ˜
2
i =
N(N + 1)
12
N∑
j=1
(pij − p¯i)
2,
respectively. An important distinction between our approach and that of Kruskal
and Wallis (1952) is that we consider permutations of the first N integers rather than
finite-sampling, hence no finite sample correction is required in our derivations.
2.2.1 The case with two samples
The following result is due to the asymptotic theory of linear rank statistics (Wald
and Wolfowitz, 1944; Ha´jek et al., 1999) and governs our test construction.
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Theorem 1. Under the null hypothesis of (2) and assumptions (A1)-(A3), the lim-
iting distribution of
LN =
R∗i − (N + 1)/2
∑N
j=1 pij
σ˜i
is standard normal with mean 0 and variance 1.
Proof. It suffices to show that the sequence (pi1, pi2, . . . , piN) satisfies the W condition
of the Wald–Wolfowitz Theorem (Wald and Wolfowitz, 1944), i.e.
N−1
∑N
j=1(pij − p¯i)
r{
N−1
∑N
j=1(pij − p¯i)
2
}r/2 = O(1), r = 3, 4, . . . .
Since 0 ≤ pij ≤ 1, with p¯i → πi, the central sample moments of the sequence
(pi1, pi2, . . . , piN) are finite:
1
N
N∑
j=1
(pij − p¯i)
r = O(1), for r = 3, 4, . . . .
Assumption (A3) ensures a non-zero variance for (pi1, pi2, . . . , piN) and hence the W
condition holds. For a detailed proof of the asymptotic normality of LN see, for
example, Theorem 6.1 of Fraser (1957).
The generalized Kruskal–Wallis test for the two-sample problem takes the form
H∗ =
(
R∗i −
N + 1
2
N∑
j=1
pij
)2/
σ˜2i , (5)
where i = 1 or 2. By Theorem 1, H∗ has an asymptotic χ2(1) distribution under the
null hypothesis. Note that it is sufficient to consider only one of the R∗i ’s in H
∗ as
R∗1 − (N + 1)/2
∑N
j=1 p1j
σ˜1
= −
R∗2 − (N + 1)/2
∑N
j=1 p2j
σ˜2
,
which can be easily verified using p1j = 1− p2j, for j = 1, . . . , N .
2.2.2 The case with three samples
For the three-sample problem, we shall consider the joint distribution of any two R∗i
and R∗i′. The covariance between R
∗
i and R
∗
i′ can be calculated as
Cov(R∗i , R
∗
i′) =
N(N + 1)
12
N∑
j=1
(pij − p¯i)(pi′j − p¯i′),
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which yields the correlation
ρ˜ii′ =
∑N
j=1(pij − p¯i)(pi′j − p¯i′)√∑N
j=1(pij − p¯i)
2
∑N
j=1(pi′j − p¯i′)
2
.
Theorem 2. Under the null hypothesis of (2) and assumptions (A1) − (A4), the
limiting distribution of
LN =
R∗i − (N + 1)/2
∑N
j=1 pij
σ˜i
and L′N =
R∗i′ − (N + 1)/2
∑N
j=1 pi′j
σ˜i′
is bivariate normal with means 0, variance 1 and correlation ρii′.
Proof. Since the sequences (pi1, pi2, . . . , piN) and (pi′1, pi′2, . . . , pi′N ) satisfy the W
condition, the result directly follows from Theorem 6.3 of Fraser (1957).
Similar to Kruskal and Wallis (1952), the generalized Kruskal–Wallis test can be
formed by considering the exponent of the bivariate normal distribution of Theorem
2, multiplied by -2,
H∗ =
1
1− ρ˜2ii′
[(
R∗i − (N + 1)/2
∑N
j=1 pij
σ˜i
)2
+
(
R∗i′ − (N + 1)/2
∑N
j=1 pi′j
σ˜i′
)2
−2ρ˜ii′
(
R∗i − (N + 1)/2
∑N
j=1 pij
σ˜i
)(
R∗i′ − (N + 1)/2
∑N
j=1 pi′j
σ˜i′
)]
, (6)
which is asymptotically distributed as χ2(2) under the null hypothesis.
An algebraic simplification of H∗ is difficult because of the pij’s. However, as in
the two-sample case, the left-out R∗ℓ , ℓ 6= i, i
′ would not be informative once R∗i and
R∗i′ are taken into account.
2.2.3 The case with more than three samples
Theorem 2 states that the joint distribution of any two linear rank statistic is asymp-
totically bivariate normal. This result together with the Cramer-Wold device yields
the joint asymptotic multivariate normality of any k − 1 linear rank statistic. Thus,
the case with k > 3 is handled by considering the correlation matrix for an arbitrary
k − 1 of the Ri’s in a similar fashion. The test statistic is formed by the exponent
of the (k − 1)-variate normal distribution after multiplication by −2 and follows an
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asymptotic χ2(k − 1) distribution under the null hypothesis. An R-code that im-
plements the generalized Kruskal–Wallis test for any k ≥ 2 is available at author’s
website.
2.3 Further Considerations
2.3.1 H-test as a special case
The generalized Kruskal–Wallis test reduces to the original Kruskal–Wallis test when
Gj is known for each subject. In this case, we define pij = (Z1j , Z2j, . . . , Zkj). Then,
R∗i = Ri and it is easy to show that
µ˜i =
N + 1
2
ni = E(Ri), σ˜
2
i =
n
12
(N + 1)(N − n) = Var(Ri),
and that
ρ˜ii′ = −
√(
ni
N − ni
)(
ni′
N − ni′
)
= Cor(Ri, Ri′), for i 6= i
′.
Hence, H-test is a special case of H∗.
Remark. A major advantage of the generalized Kruskal–Wallis test is that it does
not require a separate treatment for partially uncertain categorial data. In line with
the above approach, when Gj is available, the ranks are allocated to the corresponding
groups with probability 1, i.e. pij = (Z1j , Z2j, . . . , Zkj) and when there is uncertainty
in the group membership, the probability-weighing principle in (4) guard the testing
procedure against possible misclassifications.
2.3.2 Correction for ties
The generalized Kruskal–Wallis test can be corrected for ties in the same way as the
original Kruskal–Wallis test. When ties occur in the data, one typically assigns the
mean of the tied ranks to each member of the tied group. This specification, while
not affecting the mean rank, reduces the population variance by
∑
T/(12N) and
increases the population covariance by
∑
T/{12N(N −1)}, where T = (t−1)t(t+1)
for each group of ties, t denotes the number of ties in the group, and the summation
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is taken over all groups. Thus, in the case of ties, the variance of R∗i decreases by∑
T
12(N − 1)
N∑
j=1
(pij − p¯i)
2.
Similarly, for i 6= i′, the covariance between R∗i and R
∗
i′ is reduced by∑
T
12(N − 1)
N∑
j=1
(pij − p¯i)(pi′j − p¯i′).
The corrected generalized Kruskal–Wallis test for ties is hence obtained by sub-
stituting the adjusted σ˜i and ρ˜ii′ in H
∗. Note that, in many situations the difference
between the generalized Kruskal–Wallis test and its tie-corrected version would be
negligible barring an excessive number of ties. The R-code provided at author’s web-
site accommodates tie-correction in the generalized Kruskal–Wallis test.
2.3.3 Exact distribution
The exact null distribution of the Kruskal–Wallis test for three samples, each with up
to five observations, is given in Kruskal and Wallis (1952). More extensive tables are
later provided by Iman et al. (1975) for up to eight observations in each sample. With
a moderately large number of observations, the exact probability calculations of the
H statistic become cumbersome, even with modern computing power. In the case
of the generalized Kruskal–Wallis test, similar tabulations, even for small samples,
seem intractable due to probability weights and remain an open problem. Similar
to the suggestion of Kruskal and Wallis (1952), we recommend using the chi-square
approximation when the
∑N
j=1 pij’s are at least five.
2.3.4 Variation in group probabilities
The proposed generalized Kruskal–Wallis test is conditional on observed data. There-
fore, in our proposal, we treat the pj’s as fixed quantities that define the underlying
probability distribution of the unknown Gj’s. The treatment is reasonable for genetic
applications as there is little variation in the genotype probabilities if the same al-
gorithm is employed more than once provided the input data are the same (e.g. Pei
et al., 2008).
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In an unconditional inference, the variation in the group probabilities due to
random sampling needs to be taken into account. This amounts to specifying a
probability distribution for the pij ’s, which may not be feasible in practice. Here,
we briefly discuss the validity of the proposed test when the group probabilities are
random but treated as fixed, focusing on the case k = 2. For the distribution of the
pij ’s, while one may consider, for instance, a mixture of two beta distributions, we
prefer to keep our argument as general as possible.
Suppose the vector of probabilities {pi1, . . . , piN} are drawn independently from
a probability distribution with mean and variance satisfying conditions analogous
to (A1)-(A3). Let µ∗i and σ
∗2
i denote the unconditional mean and variance of R
∗
i ,
respectively. It is easy to see that
µ∗i =
N + 1
2
N∑
j=1
E(pij) = E(µ˜i),
and, by variance decomposition, we obtain
σ∗2i =
N(N + 1)
12
N∑
j=1
E{(pij − p¯i)
2}+
(
N + 1
2
)2 N∑
j=1
Var(pij)
= E(σ˜2i ) + Var(µ˜i),
where µ˜i and σ˜
2
i remain the conditional mean and the conditional variance of R
∗
i .
The statistic in H∗, normalized according to the conditional quantities, can be
written as
R∗i − µ˜i
σ˜i
=
σ∗i
σ˜i
(
R∗i − µ
∗
i
σ∗i
−
µ˜i − µ
∗
i
σ∗i
)
. (7)
The first quantity in the parenthesis can be shown to be asymptotically standard
normal under certain conditions similar to (A1)-(A3), and the second quantity has
an approximate normal distribution with mean zero and variance Var(µ˜i)/σ
∗2
i , by the
central limit theorem. Note that
Cov(R∗i , µ˜i) =
(
N + 1
2
)2 N∑
j=1
Var(pij) = Var(µ˜i)
and hence
R∗i − µ˜i
σ∗i
L
−→ N
(
0,
E(σ˜2i )
σ∗2i
)
.
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Using Slutsky’s theorem, we can obtain
(
R˜i − µ˜i
)
/σ˜i
L
−→ N(0, 1), provided that
σ˜2i
p
−→ E(σ˜2i ). The latter condition is satisfied when Var{(pij − πi)
2} = τ 2 > 0.
Thus, under certain assumptions, the generalized Kruskal–Wallis test statistic
remains valid when group probabilities are random. The application in Section 4
provides further evidence of this conclusion.
3 Simulations
Here we evaluate the methods via simulation studies. Specifically, (i) we evaluate the
validity of the asymptotic null distribution of the generalized Kruskal–Wallis test in
finite samples, and (ii) we compare the finite sample performance of the generalized
Kruskal–Wallis test with those of commonly used parametric tests as summarized in
Table 2. We focus on the dosage approach as it is the most popular method used
in practice, and previous work that compared various parametric approaches also
recommended its usage (Zheng et al., 2011).
Table 2. Summary of the association tests compared
Test df Incorporate Robust to
Group Uncertainty Model Assumptions
I: (p0j , p1j, p2j) is used to determine the most likely genotype group
BG-LM Best-Guess Linear Model 1 No No
BG-ANOVA Best-Guess ANOVA 2 No No
BG-KW Best-Guess Kruskal–Wallis 2 No Yes
II: (p0j , p1j , p2j) is used directly in the test
Dosage Dosage 1 Yes No
GKW Generalized Kruskal–Wallis 2 Yes Yes
3.1 Simulation Methods
As a proof of principle and being consistent with the motivation of this work, we
simulated genetic association data. Phenotype and SNP genotype data for n = 1, 000
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individuals were generated as follows.
The three genotype groups were coded as G = 0, 1 and 2 copies of the minor allele
of a SNP. The SNP of interest had a minor allele frequency of 20%, leading to expected
group size of (n0, n1, n2) = (640, 320, 40) based on the multinomial distribution with
parameters (0.64, 0.32, 0.04) under the Hardy–Weinberg equilibrium assumption. We
also considered minor allele frequency of 10% and other values.
The phenotype data were generated from an additive normal model, favorable
to the parametric methods. Without loss of generality, Y values were simulated
from normal distribution with equal mean of (2, 2, 2) under the null model, and
(1.75, 2, 2.25) under the alternative model for the three genotype groups G = 0, 1
and 2, respectively, with a common variance, σ2 = 1. The mean values were cho-
sen such that power (at the α = 0.01 level) to detect association between Y and
G is about 95% for minor allele frequency of 20% (and about 70% for minor allele
frequency of 10%) with the given sample size and without genotype uncertainty.
Other simulating parameter values were also considered with varying minor allele
frequencies, type 1 error rates and sample sizes, as well as non-normal or non-additive
models (Table S1). Additional results are provided in the Supplemental Material and
conclusions are characteristically similar to the ones reported here.
Given a true genotype G, to simulate the probabilistic genotype data, we used
the Dirichlet distribution with scale parameters a for the correct genotype category
and (1 − a)/2 for the other two, where a = 1, 0.9, 0.8, and 0.7, corresponding
to an increasing level of group uncertainty ranging from 0% to 30%. Under this
Dirichlet simulating model, the proportion of the individuals whose most probable
(best-guessed) genotypes are the correct ones is approximately a (Table 3).
For each set of probabilistic data, M = 10, 000 experiments under the null model
and 5, 000 experiments under the alternative model were conducted by simulating
only the response data. Application in Section 4 confirms that methods comparison
is not affected by how the probabilistic data were generated.
3.2 Evaluation of Accuracy
Table 4 provides the empirical type 1 error rates of the five tests considered. The
group uncertainty does not seem to alter the accuracy of any of the tests in an obvious
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Table 3. The empirical proportion of the individuals whose most probable (best-
guessed) genotypes are the correct ones. a is the Dirichlet parameter for the correct
genotype category. SNP has a minor allele frequency of 20%. Results for other frequen-
cies are similar.
a average G = 0 G = 1 G = 2
1 1.00 1.00 1.00 1.00
0.9 0.93 0.92 0.96 0.91
0.8 0.83 0.82 0.85 0.86
0.7 0.74 0.74 0.74 0.80
way. For the proposed GKW test, we also compare the quantiles of the empirical
distributions with those of the χ2(2) distribution. Figures S1 and S2 indicate that
the empirical null distribution coincides with the asymptotic one, which is further
supported by the Kolmogorov–Smirnov test with p-values 0.279, 0.595, 0.628 and
0.599 for SNP with minor allele frequency of 20% and 0.174, 0.377, 0.375 and 0.194
for SNP with minor allele frequency of 10%, from the lowest to the highest uncertainty
levels.
Table 4. Empirical type 1 error rates of the five tests at α = 0.01 under a normal null
model, for testing the association of a SNP that has minor allele frequency of 20% or
10%. a is the parameter value of the Dirichlet distribution used to simulate genotype
probabilities.
minor allele frequency = 0.2 minor allele frequency = 0.1
uncertainty level 0% 10 % 20 % 30 % 0% 10 % 20 % 30 %
(a = 1) (a = 0.9) (a = 0.8) (a = 0.7) (a = 1) (a = 0.9) (a = 0.8) (a = 0.7)
BG-LM 0.0109 0.0108 0.0090 0.0096 0.0093 0.0091 0.0095 0.0105
BG-ANOVA 0.0098 0.0106 0.0109 0.0094 0.0083 0.0089 0.0103 0.0102
BG-KW 0.0094 0.0091 0.0100 0.0097 0.0075 0.0096 0.0098 0.0094
Dosage 0.0109 0.0105 0.0091 0.0099 0.0093 0.0092 0.0095 0.0095
GKW 0.0094 0.0087 0.0091 0.0088 0.0075 0.0088 0.0092 0.0095
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3.3 Evaluation of Efficiency
We examine the empirical relative efficiency of the other tests compared to the pro-
posed generalized Kruskal–Wallis test under the alternative model, using the normal
additive data favorable to the model-based tests (Figure 1). The empirical power
of each test was obtained using the corresponding empirical type 1 error threshold
reported in Table 4. Note that, when the true genotypes are used (i.e. a = 1 with
0% group uncertainty), the GKW and the BG-KW are equivalent. This is also true
for the dosage test and the BG-LM.
As expected, the dosage has the best power when there is no group uncertainty
(Figure 1 at 0% uncertainty level), because the data were generated under the best
scenario for the dosage test (i.e. phenotype Y was normally distributed with pop-
ulation means, (1.75, 2, 2.25), increasing in an additive manner with respect to the
number of copies of the minor allele, G = (0, 1, 2)). When the minor allele frequency
is 20%, the power of the dosage test remains (slightly) higher than the generalized
Kruskal-Wallis test even as the uncertainty level increases (Figure 1(a)). However,
this is no longer true for detecting SNPs with minor allele frequency of 10% (Fig-
ure 1(b)). For example, with uncertainty level at 30% (a = 0.7), the relative efficiency
of all other tests including the dosage test is about 60% as compared to the generalized
Kruskal-Wallis test.
Moreover, in less favorable models, (e.g. Figure S7 for non-normal model), the gen-
eralized Kruskal-Wallis test can outperform the others even when there is no genotype
uncertainty. Additional simulation results with different minor allele frequencies (e.g.
0.05 and 0.3), different type 1 error rate (e.g. 0.05 and 0.001) and different model
assumptions (e.g. non-additive model) as presented in Figures S4-S8 all confirm the
robustness of the generalized Kruskal-Wallis test. Under scenarios favorable to model-
based methods, the generalized Kruskal-Wallis test provides comparable power; with
model misspecification or increased genotype uncertainty, the generalized Kruskal-
Wallis test can outperform the others.
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Figure 1. Relative efficiency of other tests as compared to the GKW test, under a
normal additive model, for testing the association of a SNP that has (a) minor allele
frequency of 20%, or (b) minor allele frequency of 10%.
4 Data Applications
We demonstrate the proposed method in three applications using data from the
genome-wide association study of complications in type 1 diabetes patients, for which
over 800K SNPs were genotyped by the Illumina 1M beadchip assay and over 1.5 mil-
lion ungenotyped SNPs were imputed (Paterson et al., 2010).
The study sample consists of n = 1, 300 subjects with type 1 diabetes (664 treated
conventionally and 636 treated intensively) from the Diabetes Control and Complica-
tions Trial (DCCT). The phenotypes of interest are glycosylated hemoglobin (HbA1c)
and diastolic blood pressure (DBP), collected quarterly from each patient over the
course of the DCCT.
The first application illustrates the case of no association using 27, 265 ungeno-
typed but imputed SNPs on chromosome 22. The other two applications evaluate the
performance of the generalized Kruskal–Wallis test in detecting putative associations
of two genotyped SNPs with DBP and HbA1c.
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4.1 P -value Distribution of H∗ on Chromosome 22
We investigated the p-value distribution of the generalized Kruskal–Wallis test using
chromosome 22 data under the null hypothesis of no association. The genotype data
at 33, 815 SNPs were imputed (provided by Dr. Andrew Paterson’s research group)
using MaCH (Li et al., 2006, 2009) using HapMap II phased data as the reference
panel. In the association analysis, we considered 27, 265 SNPs that yielded the sum
of genotype probabilities of at least five for each of the three genotype groups.
The phenotype data, mean DBP measurements over the first six study periods,
were first permuted to eliminate any possible associations. We observed that the
null distribution of p-values obtained from the χ2(2) approximation of the general-
ized Kruskal–Wallis test statistic closely matches the theoretical uniform distribution.
Figure 2 displays the corresponding quantile-quantile plot on the − log10 p scale. The
Kolmogorov–Smirnov test for uniformity yields p-value= 0.084, providing additional
evidence for the validity of the proposed generalized Kruskal–Wallis test in finite sam-
ples, because in contrast to the simulations, the group probabilities are random in
that their distributions vary between imputed SNPs and among the patient subjects.
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Figure 2. The quantile-quantile plot of the − log10(p-values) of the GKW test applied
to assess association between 27,265 imputed SNPs on chromosome 22 and permuted
diastolic blood pressure phenotype measures in 1,300 subjects with type 1 diabetes.
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4.2 DBP with rs7842868
Recently, Ye et al. (2010) identified rs7842868 on chromosome 8 as a SNP associated
with DBP with p-value ≈ 4.5× 10−8. Here, we examined the performance of the five
tests in detecting this association. Since GKW and BG-KW are readily advantaged
in the case of non-normal data, we base our comparisons on the natural logarithm of
the DBP measurements averaged over the first six study periods. The histogram of
the phenotype data for the 1, 300 patients is given in Figure 3(a).
The observed genotype data at rs7842868 yielded the group sizes (n0, n1, n2) =
(788, 446, 66). When tested for association, rs7842868 was found to be significant by
all tests with similar results (Figure 3(a) at 0% uncertainty level). GKW (equivalent
to BG-KWwhen genotypes are known) had a marginally higher statistical significance
with p-value = 1.36 × 10−8, followed by the dosage test and BG-LM with p-value =
2.66× 10−8.
We then masked the actual data and simulated 1, 000 replicates of in silico geno-
types (i.e. genotype probabilities) from the Dirichlet distribution at each group uncer-
tainty level, as described in Section 3. The results averaged over the 1, 000 replications
are shown in Figure 3(a) and verify the robustness of the GKW test. For instance,
at 10% or higher uncertainty level, the proposed GKW test had noticeable better
performance than all other procedures. Nevertheless, power to detect association by
any method deteriorated considerably as genotype uncertainty increased.
4.3 HbA1c with rs1358030
The SNP rs1358030 on chromosome 10 was reported to be genome-wide significantly
associated with HbA1c (p-value = 5× 10−9) in the conventionally treated group (Pa-
terson et al., 2010). We performed association analyses using the observed genotypes
and masked probabilistic genotypes in a fashion similar to the above DBP application.
The histogram of the phenotype, average log(HbA1c) measurements over the first
six study periods, is given in Figure 3(b). for the n = 664 conventionally treated
patients. The genotype group sizes at rs1358030 were (n0, n1, n2) = (267, 307, 90). In
this application, when the actual genotypes were used, the dosage test (equivalent
to BG-LM) showed the best performance in detecting the HbA1c association (Figure
3(b) at 0% uncertainty level). However, the advantage of the dosage test dissipated
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Figure 3. The significance, on the − log10(p-values) scale, of the association tests
at different genotype uncertainty levels for (a) DBP with rs7842868, (b) HbA1c with
rs1358030.
as the genotype uncertainty level increased.
5 Conclusions and Disucssions
In this paper, we generalized the rank-based nonparametric Kruskal–Wallis test to al-
low for group uncertainty when comparing k samples. The proposed generalized test
statistic follows an asymptotic chi-square distribution with k − 1 degrees of freedom,
suitable for statistical inference of large-scale data (e.g. genome-wide association or
next-generation sequencing data) without the need for permutation or other compu-
tationally inefficient procedures.
Although the work was originally motivated by the analyses of SNPs with genotype
uncertainty in genetic association studies, it can be readily applied to other scientific
studies. Extensive simulations and several applications showed that the generalized
Kruskal–Wallis test provides a good balance between robustness and power. Our
proof-of-principle stimulation studies could be improved to more closely mimic real
genetic data and models. However, the validity and robustness conclusion character-
istically holds, given the combined evidence from our theoretical work, and simulation
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and application studies.
The proposed generalized Kruskal–Wallis test has its limitations. For example, the
exact distribution for small samples (e.g. relevant to genetic association studies of rare
variants) is unknown. The current test does not include other covariates. However,
this limitation could be partially alleviated by considering the residuals from a regres-
sion model that accounts for the effects of other covariates first, assuming there is no
SNP-covariate interaction. Both the original and the generalized Kruskal–Wallis tests
are formulated for continuous outcomes, however, the probability-weighting principle
exploited here could potentially be extended to analyze case-control data or other
categorical outcomes and is the subject of ongoing research.
In conclusion, the proposed generalized Kruskal–Wallis test provides scientists
a tool to continue investigate, in a robust non-parametric fashion, the k-sample
problems in the presence of group uncertainty. The generalized Kruskal–Wallis test
includes the original Kruskal–Wallis test as a special case, and its power is com-
parable to parametric counterparts under conditions favorable to the model-based
approaches. When there is model misspecification or high group uncertainty, the
generalized Kruskal–Wallis test can outperform the others.
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Supplemental Material
This supplement contains the results of additional simulations under various scenarios,
as well as the tables and figures cited in the main text. Table S1 summarizes the study
purpose and the settings of our simulation studies where sample size is 1,000. Other
sample sizes (e.g. 500 or 2,000) were also studied, but results were categorically
similar, therefore not reported here.
Table S1. Reader Guide for the simulation results.
Study the impact of Power Normal Additive α MAF
minor allele frequency
Figure 1(a) yes yes 0.01 0.2
Figure 1(b) yes yes 0.01 0.1
minor allele frequency
Figure S4(a) yes yes 0.01 0.05
Figure S4(b) yes yes 0.01 0.3
type 1 error rate
Figure S5(a) yes yes 0.05 0.2
Figure S5(b) yes yes 0.001 0.2
Figure S6(a) yes yes 0.05 0.1
Figure S6(b) yes yes 0.001 0.1
model assumptions
Figure S7(a) no yes 0.01 0.2
Figure S7(b) no yes 0.01 0.1
Figure S8(a) yes no 0.01 0.2
Figure S8(b) yes no 0.01 0.1
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Figure S1. The quantile-quantile plots for the GKW test statistic, under a normal
null model, for testing the association of a SNP that has minor allele frequency of 20%.
The Kolmogorov–Smirnov test has p-values of 0.279, 0.595, 0.628 and 0.599, for the
lowest to the highest uncertainty levels.
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Figure S2. The quantile-quantile plots for the GKW test statistic, under a normal
null model, for testing the association of a SNP that has minor allele frequency of 10%.
The Kolmogorov–Smirnov test has p-values of 0.174, 0.377, 0.375 and 0.194, for the
lowest to the highest uncertainty levels.
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Figure S3. Histograms of (a) mean of the natural logarithm of DBP measurements
of 1, 300 patients over the first six study periods, (b) mean of the natural logarithm
of HbA1c measurements of 664 conventionally treated patients over the first six study
periods.
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Figure S4. Relative efficiency of other tests as compared to the GKW test at α = 0.01,
under a normal additive model, for testing the association of SNP that has (a) minor
allele frequency of 5%, (b) minor allele frequency of 30%.
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Figure S5. Relative efficiency of other tests as compared to the GKW test at (a)
α = 0.05, (b) α = 0.001, under a normal additive model, for testing the association of
SNP that has minor allele frequency of 20%.
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Figure S6. Relative efficiency of other tests as compared to the GKW test at (a)
α = 0.05, (b) α = 0.001, under a normal additive model, for testing the association of
SNP that has minor allele frequency of 10%.
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Figure S7. Relative efficiency of other tests as compared to the GKW test at α = 0.01
under a non-normal additive model, for testing the association of SNP that has (a)
minor allele frequency of 20%. (b) minor allele frequency of 10%. The non-normal data
were obtained by taking the exponent of the normal data generated as in Section 3.
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Figure S8. Relative efficiency of other tests as compared to the GKW test at α = 0.01
under a normal non-additive model, for testing the association of SNP that has (a)
minor allele frequency of 20%. (b) minor allele frequency of 10%. The data under
non-additive model were generated from normal distribution with means (1.75, 2.25, 2)
for the three genotype groups G = 0, 1 and 2, respectively, with a common variance,
σ2 = 1.
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